Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Salarius Pharmaceuticals Inc SLRX

Healthcare Biotechnology
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing treatments for parties with cancers in need of new treatment options. Its product portfolio includes seclidemstat, an oral novel small molecule inhibitor of the LSD1 enzyme and the Company's lead candidate, which is being studied as a potential treatment for pediatric cancers, sarcomas, and... see more

Recent & Breaking News (NDAQ:SLRX)

Flex Pharma Announces Establishment of Stock Purchase Plan by Chief Executive Officer

Business Wire March 9, 2015

Medtronic, Leading Neurostimulation Company, Invests in Flex Pharma IPO

Business Wire March 3, 2015

Flex Pharma Presenting at Three Upcoming Investor Conferences in March 2015

Business Wire February 26, 2015

Nobel Laureate, Rod MacKinnon, M.D., Joins Flex Pharma's Board of Directors

Business Wire February 24, 2015

AAN Selects Flex Pharma Data for Oral Platform Presentation

Business Wire February 18, 2015

Flex Pharma CEO Christoph Westphal, M.D., Ph.D., Joins BIO Emerging Companies Governing Board

Business Wire February 11, 2015

Flex Pharma Announces Closing Of Initial Public Offering

Business Wire February 4, 2015